Amplia Therapeutics CEO Talks To JustStocks Video About Recruitment Milestone for Phase2A Pancreatic Cancer Trial

Amplia Therapeutics Limited (ASX:ATX) CEO Dr Chris Burns speaks with JustStocks Video soon after announcing the company has recruited 26 patients in the Phase 2a stage of its clinical trial investigating Narmafotinib in the treatment of advanced pancreatic cancer.